Anoikis-apoptotic cell death triggered by loss of extracellular matrix (ECM) contacts is disregulated in many chronic debilitating and fatal diseases. In the autoimmune mucocutaneous diseases of pemphigus and pemphigoid excessive anoikis in the form of acantholysis or cell death by loss of cell-cell and cell-matrix contacts is the hallmark of these oral and skin lesions. In contrast, anoikis resistance contributes to cancer development and progression, and in oral squamous cell carcinoma (OSCC) anoikis resistance induces more aggressive tumors. Thus, regulating crosstalk between anoikis and survival signaling pathways is crucial to regulating tissue processes and mitigating diseases like autoimmune diseases and cancer. We recently reported that anoikis activates a CD95/Fas-mediated signaling pathway regulated by receptor-interacting protein (RIP), a kinase that shuttles between Fas-mediated cell death and integrin/FAK-mediated survival pathways in a variety of cell systems. Low RIP expression in OSCC compared to high expression levels in normal tissues underscored that RIP is at the crossroads of life and death pathways. However, it is not known how the ECM specifically interacts with the Fas receptor to mediate this mechanism and crosstalk, nor is it known how this is specifically regulated in vivo. Our preliminary data suggest that specific domains within the ECM protein fibronectin interact with the Fas receptor as the basis for this anoikis regulation. In addition, a Fas receptor mutation, which results in an inability of Fas to bind it's ligand, renders cells anoikis resistant in our system, further supporting a connection between the Fas receptor and specific domains of fibronectin. The fact that this Fas receptor mutation manifests as an autoimmune syndrome in humans (Canale-Smith syndrome) reaffirms the importance of apoptotic disregulation in autoimmune diseases. Since, there have been no reports of death receptors, like Fas interacting with ECM proteins, this constitutes a completely new area of investigation. On the survival side of the equation, we further found that sirtuins, a novel family of NAD- dependent deacetylases recently discovered to be involved in prolonging longevity and in cancer progression and metastasis, confer a survival advantage to OSCC cells. Thus, sirtuins may be important in promoting anoikis resistance in cells. Our global hypothesis is that disregulation of anoikis mediated by Fas- fibronectin interactions is central to many disease processes. Our specific hypothesis is that there are direct Fas-fibronectin interactions that mediate crosstalk with integrins to regulate anoikis via downstream signaling to RIP. Furthermore, anoikis resistant cells bypass this signaling pathway and favor sirtuin signaling to support their survival and a more aggressive phenotype in vivo. Knowledge gained from these investigations will help decipher novel interactions between matrix proteins and cell death receptors, and expand our understanding of life and death signaling networks. These data may help identify critical therapeutic targets for diseases like autoimmune diseases and oral cancer.

Public Health Relevance

The purpose of this project is to understand how the extracellular matrix regulates the survival and death/anoikis of cells and how these mechanisms are regulated in vivo. Our global hypothesis is that disregulation of anoikis is central to many disease processes. For example, ability to evade programmed cell death, or apoptosis/anoikis, is a key factor in cancer development and progression. In addition, anoikis is central to autoimmune diseases and to many other tissues processes;therefore these studies have broad implications to many fields.

National Institute of Health (NIH)
National Institute of Dental & Craniofacial Research (NIDCR)
High Priority, Short Term Project Award (R56)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-MOSS-B (02))
Program Officer
Venkatachalam, Sundaresan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Schools of Dentistry
Ann Arbor
United States
Zip Code
Alhazzazi, Turki Y; Kamarajan, Pachiyappan; Xu, Yanli et al. (2016) A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells. Anticancer Res 36:49-60
Alhazzazi, Turki Y; Kamarajan, Pachiyappan; Verdin, Eric et al. (2013) Sirtuin-3 (SIRT3) and the Hallmarks of Cancer. Genes Cancer 4:164-71
Kamarajan, Pachiyappan; Shin, Jae M; Qian, Xu et al. (2013) ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC. Cancer Med 2:793-802
Joo, Nam E; Ritchie, Kathryn; Kamarajan, Pachiyappan et al. (2012) Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med 1:295-305
Kamarajan, Pachiyappan; Alhazzazi, Turki Y; Danciu, Theodora et al. (2012) Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis. Cancer 118:5800-10
Tripathi, Pratima; Kamarajan, Pachiyappan; Somashekar, Bagganahalli S et al. (2012) Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target. Int J Biochem Cell Biol 44:1852-61
Alhazzazi, Turki Y; Kamarajan, Pachiyappan; Joo, Nam et al. (2011) Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer 117:1670-8
Bunek, J; Kamarajan, P; Kapila, Y L (2011) Anoikis mediators in oral squamous cell carcinoma. Oral Dis 17:355-61
Somashekar, Bagganahalli S; Kamarajan, Pachiyappan; Danciu, Theodora et al. (2011) Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues. J Proteome Res 10:5232-41
Alhazzazi, Turki Y; Kamarajan, Pachiyappan; Verdin, Eric et al. (2011) SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta 1816:80-8